Attachment 4. 60-day FRN

Attachment 4.

Federal Register Notice (60 day)

2529

Federal Register / Vol. 72, No. 12 / Friday, January 19, 2007 / Notices
ESTIMATE OF ANNUALIZED BURDEN HOURS—Continued
Number of
respondents

Form
—Salmonella (electronic) .....................................................................................................
—Shigella (electronic) ..........................................................................................................
Foodborne Outbreak Form ...................................................................................................
Arboviral Surveillance (ArboNet) ..........................................................................................
Influenza:
—Influenza virus (fax, Oct–May) ..........................................................................................
—Influenza virus (fax, year round) .......................................................................................
*** Influenza virus (Internet; Oct–May) .................................................................................
*** Influenza virus (Internet; year round) ..............................................................................
—Influenza virus (electronic, Oct–May) ...............................................................................
—Influenza virus (electronic, year round) ............................................................................
Influenza Annual Survey ......................................................................................................
Influenza-like Illness (Oct–May) ...........................................................................................
Influenza-like Illness (year round) ........................................................................................
Monthly Respiratory & Enterovirus Surveillance Report:
—Excel format (electronic) ...................................................................................................
National Respiratory & Enteric Virus Surveillance System (NREVSS) ...............................
Rabies (electronic) ................................................................................................................
Rabies (paper) ......................................................................................................................
Waterborne Diseases Outbreak Form .................................................................................
Cholera and other Vibrio illnesses .......................................................................................
Calicivirus surveillance (CaliciNet) .......................................................................................
Listeria Case Form ...............................................................................................................

Deborah Holtzman,
Reports Clearance Officer, Centers for Disease
Control and Prevention.
[FR Doc. E7–704 Filed 1–18–07; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–07–07AG]

sroberts on PROD1PC70 with NOTICES

Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Joan F. Karr, CDC
Acting Reports Clearance Officer, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an e-mail to
[email protected].
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the

VerDate Aug<31>2005

18:10 Jan 18, 2007

Jkt 211001

agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
National HIV Behavioral Surveillance
System (NHBS)—New—National Center
for HIV, STD, and TB Prevention
(NCHSTP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The purpose of this data collection is
to monitor behaviors related to Human
Immunodeficiency Virus (HIV) infection
among persons at high risk for infection
in the United States. The primary
objectives of the system are to obtain
data from samples of persons at risk to:
(a) Describe the prevalence and trends
in risk behaviors; (b) describe the
prevalence of and trends in HIV testing
and HIV infection; (c) describe the
prevalence of and trends in use of HIV
prevention services; (d) identify met and
unmet needs for HIV prevention
services in order to inform health
departments, community based
organizations, community planning
groups and other stakeholders. This
project addresses the goals of CDC’s HIV
prevention strategic plan, specifically

PO 00000

Frm 00040

Fmt 4703

Sfmt 4703

Number of
responses

Avg. burden

53
53
54
57

52
52
25
1421

3/60
3/60
15/60
4/60

8
15
13
24
9
14
83
824
496

33
52
33
52
33
52
1
33
52

10/60
10/60
10/60
10/60
5/60
5/60
15/60
15/60
15/60

25
90
50
3
57
450
20
53

12
52
12
12
1
1
5
1

15/60
10/60
8/60
15/60
20/60
20/60
5/60
30/60

the goal of strengthening the national
capacity to monitor the HIV epidemic to
better direct and evaluate prevention
efforts.
Data are collected through in-person
interviews conducted with persons
systematically selected from 25
Metropolitan Statistical Areas (MSAs)
throughout the United States; these 25
MSAs were chosen based on having
high AIDS prevalence. Persons at risk
for HIV infection to be interviewed for
NHBS include men who have sex with
men (MSM), injecting drug users (IDU),
and heterosexual persons living in
census tracts that have high HIV/AIDS
prevalence (HET). A brief screening
interview will be used to determine
eligibility for participation in the full
survey. The data from the full survey
will provide estimates of behavior
related to the risk of HIV and other
sexually transmitted diseases, prior
testing for HIV, and use of HIV
prevention services. All persons
interviewed will also be offered an HIV
test, and will participate in a pre-test
counseling session. No other federal
agency systematically collects this type
of information from persons at risk for
HIV infection. This data will have
substantial impact on prevention
program development and monitoring at
the local, state, and national levels.
CDC estimates that NHBS will
involve, per year in each of the 25
MSAs, eligibility screening for 50 to 200
persons and eligibility screening plus
the survey and HIV testing with 500
eligible respondents, resulting in a total
of 37,500 eligible survey respondents

E:\FR\FM\19JAN1.SGM

19JAN1

2530

Federal Register / Vol. 72, No. 12 / Friday, January 19, 2007 / Notices

and 7,500 ineligible screened persons
during a 3-year period. Data collection
will rotate such that interviews will be
conducted among one group per year:

MSM in year 1, IDU in year 2, and HET
in year 3. The type of data collected for
each group will vary slightly due to
different sampling methods and risk

characteristics of the group.
Participation of respondents is
voluntary and there is no cost to the
respondents other than their time.

ESTIMATED ANNUALIZED BURDEN HOURS

MSM:
Screener only ...........................................................................................
Screener, survey, and testing ..................................................................
IDU:
Screener only ...........................................................................................
Screener, survey, and testing ..................................................................
HET:
Screener only ...........................................................................................
Screener, survey, and testing ..................................................................
Total ...................................................................................................

Dated: January 12, 2007.
Deborah Holtzman,
Reports Clearance Officer, Centers for Disease
Control and Prevention.
[FR Doc. E7–705 Filed 1–18–07; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Breast and Cervical Cancer Early
Detection and Control Advisory
Committee

sroberts on PROD1PC70 with NOTICES

In accordance with section 10(a)(2)of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned
committee meeting:
Times and Dates: 8:30 a.m.–5 p.m.,
February 6, 2007; 8:30 a.m.–3 p.m., February
7, 2007.
Place: Centers for Disease Control and
Prevention, 1600 Clifton Road, NE., Tom
Harkin Global Community Center, Building
19, Atlanta, Georgia 30333, Telephone: 404–
639–1717.
Status: Open to the public, limited only by
the space available.
Purpose: The committee is charged with
advising the Secretary, Department of Health
and Human Services, and the Director, CDC,
regarding the early detection and control of
breast and cervical cancer. The committee
makes recommendations regarding national
program goals and objectives;
implementation strategies; and program
priorities including surveillance,
epidemiologic investigations, education and
training, information dissemination,
professional interactions and collaborations,
and policy.

VerDate Aug<31>2005

18:10 Jan 18, 2007

Jkt 211001

Number of
responses per
respondent

Number of
respondents

Respondents

1
1

5/60
65/60

417
13,542

1,250
12,500

1
1

5/60
90/60

104
18,750

1,250
12,500

1
1

5/60
75/60

104
15,625

........................

........................

........................

48,542

Dated: January 12, 2007.
Edward Schultz,
Acting Director, Management Analysis and
Services Office, Center for Disease Control
and Prevention.
[FR Doc. E7–721 Filed 1–18–07; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Clinical Laboratory Improvement
Advisory Committee
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following committee
meeting.
Name: Clinical Laboratory Improvement
Advisory Committee (CLIAC). Web site:

Frm 00041

Fmt 4703

Total burden
(in hours)

5,000
12,500

Matters to be Discussed: The agenda will
include a review and discussion of the
National Breast and Cervical Cancer Early
Detection Program components; and
discussion and review of related policies and
emerging issues.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Debra Younginer, Executive Secretary,
BCCEDCAC, Division of Cancer Prevention
and Control, National Center for Chronic
Disease Prevention and Health Promotion,
CDC, 4770 Buford Highway, Mailstop K–57,
Chamblee, Georgia 30316, Telephone: 770–
488–1074.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both CDC and NCEH/ATSDR.

PO 00000

Average
burden per
response
(in hours)

Sfmt 4703

http://www.phppo.cdc.gov/CLIAC/
default.aspx.
Times and Dates: 8:30 a.m.–5 p.m.,
February 14, 2007; 8:30 a.m.–3 p.m.,
February 15, 2007.
Place: Omni Hotel at CNN Center, 100
CNN Center, Atlanta, Georgia 30303; Phone:
(404) 659–0000, Fax: (404) 525–5050 (http://
www.omnihotels.com/FindAHotel/
AtlantaCNNCenter.aspx).
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 100 people.
Purpose: This committee is charged with
providing scientific and technical advice and
guidance to the Secretary of Health and
Human Services, the Assistant Secretary for
Health, and the Director, CDC, regarding the
need for, and the nature of, revisions to the
standards under which clinical laboratories
are regulated, the impact on medical and
laboratory practice of proposed revisions to
the standards, and the modification of the
standards to accommodate technological
advances.
Matters to be Discussed: The agenda will
include updates from the CDC, the Centers
for Medicare & Medicaid Services, and the
Food and Drug Administration; discussion of
the status of the ‘‘Notice of Proposed
Rulemaking’’ for genetic testing;
presentations and discussion concerning the
future of health laboratory practice
specifically focusing on simple testing in
diverse sites; reports and discussions
addressing the impact of the Morbidity and
Mortality Weekly Report (MMWR)
Publication of ‘‘Good Laboratory Practices for
Waived Testing Sites’’; a report from the
CLIAC Workgroup on ‘‘The Impact of Rapid
and Molecular Tests for Infectious Disease
Agents on Public Health’’ and discussion of
the workgroup’s proposals related to such;
and presentations and discussion concerning
rapid HIV testing. Agenda items are subject
to change as priorities dictate.
Providing Oral or Written Comments: It is
the policy of CLIAC to accept written public
comments and provide a brief period for oral
public comments whenever possible.

E:\FR\FM\19JAN1.SGM

19JAN1